Cargando…

Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer

OBJECTIVE: CD47 is an antiphagocytic molecule that contributes to tumor cell resistance in host immune surveillance. CD47 overexpression correlated with tumor progression and shorter survival in lung cancer. However, the expression and functional significance of CD47 in Non‐Small Cell Lung Cancer (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arrieta, Oscar, Aviles‐Salas, Alejandro, Orozco‐Morales, Mario, Hernández‐Pedro, Norma, Cardona, Andrés F., Cabrera‐Miranda, Luis, Barrios‐Bernal, Pedro, Soca‐Chafre, Giovanny, Cruz‐Rico, Graciela, Peña‐Torres, María de Lourdes, Moncada‐Claudio, Guadalupe, Ramirez‐Tirado, Laura‐Alejandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131854/ https://www.ncbi.nlm.nih.gov/pubmed/32043750 http://dx.doi.org/10.1002/cam4.2882

Ejemplares similares

Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
por: Orozco-Morales, Mario, et al.
Publicado: (2016)

Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients
por: Soca-Chafre, Giovanny, et al.
Publicado: (2018)

Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
por: Orozco-Morales, Mario, et al.
Publicado: (2021)

Multiple Molecular Targets Associated with Genomic Instability in Lung Cancer
por: Soca-Chafre, Giovanny, et al.
Publicado: (2019)

Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial–Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells
por: Barrios-Bernal, Pedro, et al.
Publicado: (2022)

Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses
por: Barrios-Bernal, Pedro, et al.
Publicado: (2022)

CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
por: Catalán, Rodrigo, et al.
Publicado: (2020)

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Calcitriol Inhibits the Proliferation of Triple-Negative Breast Cancer Cells through a Mechanism Involving the Proinflammatory Cytokines IL-1β and TNF-α
por: Martínez-Reza, Isela, et al.
Publicado: (2019)

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
por: Avilés-Salas, Alejandro, et al.
Publicado: (2022)

Curcumin inhibits activation induced by urban particulate material or titanium dioxide nanoparticles in primary human endothelial cells
por: Montiel-Dávalos, Angélica, et al.
Publicado: (2017)

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Modifying factors of PD‐L1 expression on tumor cells in advanced non‐small‐cell lung cancer
por: Avilés‐Salas, Alejandro, et al.
Publicado: (2022)

Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications
por: Rodriguez-Lara, Vianey, et al.
Publicado: (2023)

Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
por: Yang, Hongcheng, et al.
Publicado: (2019)

An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
por: Wang, Xinmin, et al.
Publicado: (2021)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
por: Yoshida, Kazumichi, et al.
Publicado: (2015)

Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status
por: Arrieta, Oscar, et al.
Publicado: (2020)

Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
por: Horrigan, Stephen K
Publicado: (2017)

Escuela primaria ford 47. /
por: Falfán Hernández, Pedro Eleuterio
Publicado: (2000)

Identification of potential biomarkers from microarray experiments using multiple criteria optimization
por: Sánchez-Peña, Matilde L, et al.
Publicado: (2013)

Syncytin 1, CD9, and CD47 regulating cell fusion to form PGCCs associated with cAMP/PKA and JNK signaling pathway
por: Fei, Fei, et al.
Publicado: (2019)

Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy
por: Rojas‐Puentes, Leonardo, et al.
Publicado: (2016)

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells
por: Cruz-Rico, Graciela, et al.
Publicado: (2021)

TIGIT blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
por: Brauneck, Franziska, et al.
Publicado: (2022)

A nomogram to predict outcomes of lung cancer patients after pneumonectomy based on 47 indicators
por: Cheng, Bo, et al.
Publicado: (2020)

Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser
por: Gnanapradeepan, Keerthana, et al.
Publicado: (2020)

Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patients
por: Arrieta, Oscar, et al.
Publicado: (2022)

Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
por: Schürch, Christian M., et al.
Publicado: (2019)

Actinomycetoma by Actinomadura madurae: Clinical Characteristics and Treatment of 47 Cases
por: Bonifaz, Alexandro, et al.
Publicado: (2021)

Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib
por: Avilés‐Vázquez, Sócrates, et al.
Publicado: (2017)

The RAGE/multiligand axis: a new actor in tumor biology
por: Rojas, Armando, et al.
Publicado: (2022)

Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer
por: Hernández-Pedro, Norma, et al.
Publicado: (2023)

Clinical Impact of the COVID‐19 Pandemic in Mexican Patients with Thoracic Malignancies
por: Arrieta, Oscar, et al.
Publicado: (2021)

Sex chromosome aneuploidies and fertility: 47,XXY, 47,XYY, 47,XXX and 45,X/47,XXX
por: Rogol, Alan D
Publicado: (2023)

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
por: Chen, Shih-Hsun, et al.
Publicado: (2021)

The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
por: Arrieta, Oscar, et al.
Publicado: (2007)

Large‐scale topological disruption of chromosome territories 9 and 22 is associated with nonresponse to treatment in CML
por: Fabian‐Morales, Eunice, et al.
Publicado: (2021)

Rare cancers of unknown etiology: lessons learned from a European multi-center case–control study
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_duf37t32r3lfi8pqqrmo07r0g4